EMEA-001895-PIP01-15-M01

Table of contents

Key facts

Active substance
Lactobacillus reuteri (IBP-9414)
Therapeutic area
  • Gastroentology-Hepatology
  • Neonatology-Paediactric Intensive care
  • Other
Decision number
P/0314/2021
PIP number
EMEA-001895-PIP01-15-M01
Pharmaceutical form(s)
Powder for oral suspension
Condition(s) / indication(s)
Prevention of necrotising enterocolitis
Route(s) of administration
Gastroenteral use
Contact for public enquiries
Infant Bacterial Therapeutics AB

Tel. +46841014555
E-mail: info@ibtherapeutics.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating